Healthcare and Cars are Not Isomorphic

I've recently been doing some thinking about health care, and my thoughts aren't yet complete. However, when reading many of the conservative commentaries on health care, I was very peeved by their treatment of the market for health care just like the market for any other good or service, and this was aggravated by the fact that I agreed with most of their other arguments. As a result, I wrote the following NextGen article to collect my thoughts on this issue before I move on to more substantive analyses of some recent posts.

..................................................
"Healthcare and Cars: Why They're Not the Same"


How is the market for health care different from that for cars? And how does this difference change our understanding of health care policy?

Let us start from the basics: health care is a service, while a car is a good. While this does not prevent market competition from improving society's welfare on the margin, it does mean that there are fundamental limits to how far the market can improve. In particular, it means that one productive hospital cannot simply “export” its health care services across the country. And as we know from the car industry and international trade theory, that lack of export markets and distant competitors can impede the creative destruction that makes markets work.

But this is an incomplete justification. Haircuts are also services, but few people think barbershops require regulation. Yet, they differ in one key respect. While it is easy for me  to determine the quality of my haircut, it is much more difficult for me to determine what counts as “good” health care. A large part of this is linked to the uncertainty inherent in any kind of biological process. How does one determine if one is receiving sufficient care? Of course, if there is any gross negligence, it can be detected. Yet if the care is just slightly worse than it should be, there's no real way for the consumer to know. The problem is compounded by the fact that most people rarely get sick. If you go to get a haircut every month, you can quickly determine which barbershop is the best. Unfortunately for neoclassical economists but fortunately for society as a whole, people need catastrophic care substantially less often than they need haircuts, thereby impeding the market from finding the most efficient solution.

Chronic care does change the calculation, but it introduces other factors that again prevent the market for health care from functioning like the market for cars. To take a concrete example, consider the 40 million elderly individuals who suffer from arthritis. Does it make sense to ask them to “shop around” to find the perfect hospital? Does it make sense to ask them to trust in an online service like Yelp to decide where to get care? And when they are fatigued by chronic pain, does it make sense to think they can make the “optimal” choice, and not just the most convenient?

Other problems make it difficult for the market for health care insurance to function like a regular competitive market. Again, a parallel to the market for cars, in particular used cars, is helpful. A problem with used car markets is that it's not entirely clear whether the car you wish to purchase is good or bad. This depresses the market value of used cars, both good and bad. But then producers of the more expensive good cars exit the market, further lowering the average quality of a used car until the market spirals out of existence. The market for health care is subject to similar pressures, but in the opposite direction. For insurers, they cannot easily tell whether an applicant is healthy or not. As a result, they charge the same premium to all individuals, which leads to healthy individuals dropping out of the market because they value the insurance less. This process repeats itself until premiums spiral upwards and no market for health care insurance exists.

This describes what economists call adverse selection, and although it is a market failure, it doesn't mean the government always needs to step in. However, understanding how the market circumvents the problem helps us understand why a simple solution for the health insurance does not exist. For example, markets for used cars can exist because the salesmen can offer warranties, so that if the car does break down you can “turn back the clock” on the purchase and return the car. This reduces the incentive for used car salesmen to trick you into buying lemons, because if the car does turn out to be a lemon you can always return it.

But what would a similar system mean for health care insurance? In that market, it's the consumer who has the private knowledge, therefore it falls to the consumer to make the “warranty”. This would mean the consumer would have to be able to guarantee that he or she won't become more unhealthy in the future – an impossible task. Alternatively, insurance companies can “turn back the clock” and refuse to pay for the consumer on the ground that the consumer was unhealthier than was expected. This hardly seems like an efficient or moral outcome, and is precisely the reason why the protections for preexisting conditions is so popular in the ACA.

With these stylized facts, it should be abundantly clear that the markets for health care and insurance are very different from what the standard competitive model predicts. Hence, we need to be very cautious when we draw glib analogies from health care to cars. However, the implications for policy are mixed. On one hand, certain regulatory reforms such as cutting the employer health care deduction, reducing occupational licensing barriers, and relaxing privacy laws can result in substantial advances towards improving health care. Yet the presence of these government failures does not mean that there is no role for the government to ameliorate the market pathologies that I have listed above.

A notable example of this is the individual mandate. The individual mandate, by forcing people to purchase insurance, massively expands the market for health care. In doing so, this increases the incentive for firms to pursue innovative new projects to increase productivity. And even though consumers still rarely need catastrophic care, the larger market allows transparency and reputation to have an effect as hospitals are at greater risk to lose customers. For the insurance market, an individual mandate can help pull us away from the adverse selection death spiral by preventing self selection and thereby keeping most of the population insured.

In other words, the government is not perfect, but neither is the market. By noting that the market for health care is fundamentally different from that for other goods such as cars, we can recognize why the standard assumptions for regular markets may not apply in the case for health care. As such, we must move forward with caution, with an understanding that true reform lies not with complete liberalization or complete regulation, but rather with a judicious mix of the two.
......................

Update 10/24/12 -- I was pleasantly surprised to find that this post was heavily discussed in Reddit. I just wanted to put a few points to defend myself from a series of very informative critiques.

• I never oppose market reforms like HSA's or cutting the employer healthcare tax deduction. That's not in my post at all.
• The point of the post is to highlight some frictions in the healthcare market that justify some sort of intervention -- market based (preferably) or command and control (not ideal).

Nominal GDP Targeting: An Introduction with Market Applications

A few weeks ago, I joined Michigan Interactive Investments, the premier finance club at the University of Michigan. Every week during our meetings, we have a market update during which we sound off our opinions on recent market events. And, as readers know, I take a great interest in monetary policy and have been very vocal about the positives behind the Federal Reserve's recent moves in terms of QE3 and conditional forward guidance.

However, I find that there's a disconnect between my understanding and perception of monetary policy and that of my fellow peers at MII. My suspicion is that it has something to deal with the differences between practitioners and academics, but I am still unsure of the specific difference. As a result, I prepared a presentation on this issue and wanted to share it with the rest of the blogosphere. I consider this different from Evan's excellent post on the layman's guide to NGDP targeting for two key reasons. First, this is targeted for those who are already financially literate -- ie they know what treasury bonds and other financial indicators are. Second, it's meant to be more visual to drive the point home in a presentation.

Considering I used quite a few graphs that have been inspired by debates I've encountered through blogging, I thought it would be apropos to present it here first. I hope it is useful for explaining nominal GDP targeting to a more technical financial crowd or undergraduate economics students. As always, comments are encouraged, and I'm happy to revise the presentation if I missed something.

Notes on a Healthcare Talk

Yesterday at the Ross School of Business, there was a panel discussion on health care in the United States. Jonathan Gruber and  Katherine Baicker, two well known health economists, in addition to David Leonhardt, a New York Times reporter who has reported extensively the health care debate, gave their perspectives on health care in the United States.

What I found was quite interesting was how much of a consensus there was among health care economists. Yes, the health care market fails for the 46 million uninsured Americans. No, providing more health care for people doesn't reduce spending on health care. But yes, there are major tax and market reforms that the government can do to increase the value of health care delivered in the United States.

Gruber was the first speaker, and I found his defense of the ACA quite witty. He characterized health care reform as a three legged stool that depends on three parts -- coverage expansion, individual mandate, and subsidies -- to fully function. Because pre-existing conditions can cause people to be kicked off the rolls when they need it most, it's important to reform coverage laws to allow more people to buy insurance. But then if there's no individual mandate, the market is subject to adverse selection. It is, as Gruber joked, "like forcing sports bookies to take bets at half-time". And to make sure that people can afford to purchase insurance, the government has to provide subsidies to increase affordability.

Something else that Gruber emphasized during the talk was that the health care debate is highly nuanced, and that talk of reform shouldn't be on partisan lines. The Affordable Care Act is not a government takeover of health care -- it merely creates a new market in which private insurers can innovate and thrive. Nor is it a federal takeover of health care delivery -- states are allowed large levels of discretion in how they implement their health care exchanges. Something that both Gruber and Baicker seemed excited about was the possible policy innovations the ACA may stimulate. The ACA, while it is certain in the coverage expansion, is much less certain on how to control costs. It is hoped that the variety of reforms -- capping the employer tax deduction, pilot programs for alternative health care delivery, and comparative effectiveness research -- can eventually discover something that the market will find valuable and later deploy.

We already see some of this innovation in the reform of fee-for-service payments. For two years, Blue Cross and Blue Shield of Massachusetts has already been trying out an alternative payment structure that focuses on patient wellness rather than the number of office visits. And then in the past week, Medicare took its first step away from fee-for-service by penalizing readmission and rewarding hospitals that deliver better care with higher payments. Later during the Q and A session, Baicker mentioned other possibilities, such as integrated health care units or even simple emails from your doctor, in order to improve health care effectiveness.

Gruber and Baicker were both optimistic that these kinds of reforms would be critical in bringing costs down. Baicker often mentioned that increasing coverage is easy -- the question is how to control costs. Yet, for both Gruber and Baicker, this ignorance about cost control was just a better reason to expand coverage first. We know how to expand coverage, we don't know how to expand costs. So, as Leonhardt noted, let's expand coverage to save lives now, and use what we learn from the new practices in the health care market to try to reduce costs on a national level.

I find this approach eminently sensible. As mentioned above, reform is critical to creating a larger market for health care, and it seems to be a natural result that the resulting market will have a greater variety of business models and payment structure innovations. Given that ideas can quickly spread, the efficiency of the system will ultimately be determined by the efficiency of the best, not the average. As such, increasing the number of health care consumers seems to be the first step towards discovering a solution to rising health care costs. Gruber also argued that this would help solve the primary care doctor shortage by changing the incentives for medical students. By changing the way insurers reimburse for services, this would reduce the demand for specialty medicine, and thus push more doctors out of specialty disciplines and into primary care.

Baicker made a statement that I feel is very important in framing discussions in health economics: "Health ≠ Health Care ≠ Health Insurance". From all the above analysis, we know this to be true. Just because something is a health care service, such as proton beam therapy, doesn't mean it improves health. And just because something improves health, such as phone calls from a physician, doesn't mean we think of it as "health care". And to properly fund all of this, we need a robust system of insurance that requires incentives and cost structures that are not directly related to a person's biological condition, but nonetheless change the way health care is delivered. The fact that this is true means that when we move forward with the health care system, we need to consider each of those three related, but distinct, parts.